Boston Scientific Receives FDA Approval for Next-Generation WATCBSX: Boston Scientific Corporation
2020-07-21 16:24:00
Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device
BSX trade ideas
Bullish Charts - Golden CrossBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Daily Chart - Golden Cross
Stochastic is moving up, Bullish
RSI is crossing center line, Bullish
Volume just went green on the daily
I think the stock is getting ready to move higher.
I also think, BSX is one of the cheapest medical device companies in the industry.
Long
There's Nothing Scientific about a Momentum Burst!What I see...
+ MACD is cutting upward in bullish zone
+ RSI is rising at 56.8
+ Nice hammer ended the week at just under the top of the channel
+ Prices have been range-bounded in the past 2 months
+ Very high vol. -2w
+ NR7 on -1d
:: I would like the prices to move sideway for a bit longer to wait for the 10ma to pull up
:: I'm setting up an entry just in case it breaks out with little warning
- Price has drifted a bit away from the 10ma
- First Resistance at range high set in mid-April; Second Resistance at 200ma
- It's been multiple up days in a row
What I setup
+ Long entry above range
- Stop at bottom of the doji on -1d
+ Target at 44
:: Duration - months
** Comments and Likes are appreciated; New Subscribers are scientific! **
Short the Red box :OWe have a good shorting Opp here. Its showing signs of reversal on most timeframes especially the larger ones such at the Month, Week and Daily.
Noone can see 3-4 years into the future right? Well I'm no different so dont take this as financial advice more of just a hey this looks ok to me sort of thing. Ive taken the time to give you a Fan, a Triangle, and major resistance and support levels on larger time frames. Take the time do your own research but hope this helps guide some in the right direction Enjoy :)
Purple is Monthy
Yellow is weekly
White is Heavy resistance/support lines due to large moves up/down
Red Box: Short Area
Overall Target it is 18-19, with potential to break through to 7-8
$BSX BOSTON SCIENTIFIC HAS TROUBLE AHEAD.Yesterdays enforcement by the FDA for BSX to remove one of its products from the market is a significant blow to BSX and has sent investors running scared. Fears from legal actions by clients are a definite and real possibility which will send the price into further correction in out opinion.
